REGINA WALKER ROBERTSON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CEDAR HILL, TX NPI 1609466978

General Payments — all program years on this page

$417.44

  • Category: General Payments
  • Program years: PY2022–2023
  • Record count: 18
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $351.50 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $351.5014

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Stemline Therapeutics Inc. $120.961
Novo Nordisk AS $112.206
GlaxoSmithKline, LLC. $70.494
Lilly USA, LLC $32.832
Acerta Pharma LLC $15.021

By program year

Program yearAmountRecords
2022 $65.944
2023 $351.5014

Records — PY2023 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1002626117 Novo Nordisk Inc $16.33 01/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002626127 Novo Nordisk Inc $17.38 08/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002626139 Novo Nordisk Inc $17.64 04/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002626151 Novo Nordisk Inc $18.60 02/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002626163 Novo Nordisk Inc $19.80 10/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002626175 Novo Nordisk Inc $22.45 02/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003863445 GlaxoSmithKline, LLC. $19.97 02/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003863461 GlaxoSmithKline, LLC. $20.45 01/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003863835 GlaxoSmithKline, LLC. $15.06 08/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003863873 GlaxoSmithKline, LLC. $15.01 06/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1012052711 AstraZeneca Pharmaceuticals LP $15.02 03/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1033194763 Lilly USA, LLC $15.77 01/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1033194769 Lilly USA, LLC $17.06 02/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1040053591 Stemline Therapeutics Inc. $120.96 06/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.